Synergistic combination therapy with cotylenin A and vincristine in multiple myeloma models
Tsutomu Takahashi(Shimane University Hospital), Junji Suzumiya(Koga Hospital), Satoshi Kumanomidou(Shimane University Hospital), Ichiro Moriyama(Shimane University Hospital), Chie Onishi(Shimane University Hospital), Yumi Jo(Shimane University Hospital), Fumiyoshi Ikejiri(Shimane University), Koshi Kawakami(Osaka University of Economics), Yoshio Honma(National Cancer Center Hospital East), Masaya Inoue(Shimane University), Masahiro Okada(Shimane University Hospital), Junko Tanaka(Chiba University), Takaaki Miyake(Shimane University), Saki Takami(Shimane University Hospital)
Cited by 16
Related Papers
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
|Proceedings of the National Academy of Sciences|1983|255
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
|Journal of Lipid Research|2004|156
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149
Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids
|Biochemical and Biophysical Research Communications|1980|120